-
2
-
-
4243269108
-
On paralysis agitans (Lecture V)
-
London, UK: New Sydenham Society;
-
Charcot J-M. On paralysis agitans (Lecture V). In: Lectures on the Disease of the Nervous System. London, UK: New Sydenham Society; 1877:129-156.
-
(1877)
Lectures on the Disease of the Nervous System
, pp. 129-156
-
-
Charcot, J.-M.1
-
3
-
-
4644319867
-
Memory systems of the brain: a brief history and current perspective
-
Squire LR. Memory systems of the brain: a brief history and current perspective. Neurobiol Learn Mem 2004;82:171-177.
-
(2004)
Neurobiol Learn Mem
, vol.82
, pp. 171-177
-
-
Squire, L.R.1
-
4
-
-
0022930826
-
Parallel organization of functionally segregated circuits linking basal ganglia and cortex
-
Alexander GE, DeLong MR., Strick PL. Parallel organization of functionally segregated circuits linking basal ganglia and cortex. Ann Rev Neurosci. 1986:9:357-381.
-
(1986)
Ann Rev Neurosci.
, vol.9
, pp. 357-381
-
-
Alexander, G.E.1
DeLong, M.R.2
Strick, P.L.3
-
5
-
-
0020636876
-
Cognitive deficits in the early stages of Parkinson's disease
-
Lees AJ, Smith E. Cognitive deficits in the early stages of Parkinson's disease. Brain 1983;106:257-270.
-
(1983)
Brain
, vol.106
, pp. 257-270
-
-
Lees, A.J.1
Smith, E.2
-
6
-
-
0021260072
-
Visuospatial impairments in Parkinson's disease: role of perceptual and motor factors
-
Boller F, Passafiume D, Keefe NC, et al. Visuospatial impairments in Parkinson's disease: role of perceptual and motor factors. Arch Neurol 1984;41:485-490.
-
(1984)
Arch Neurol
, vol.41
, pp. 485-490
-
-
Boller, F.1
Passafiume, D.2
Keefe, N.C.3
-
7
-
-
0023025132
-
Frontal lobe dysfunction in Parkinson's disease
-
Taylor AE, Saint-Cyr JA, Lang AE. Frontal lobe dysfunction in Parkinson's disease. Brain 1986;109:845-883.
-
(1986)
Brain
, vol.109
, pp. 845-883
-
-
Taylor, A.E.1
Saint-Cyr, J.A.2
Lang, A.E.3
-
8
-
-
0023128752
-
Parkinson's disease: cognitive changes in relation to treatment response
-
Taylor AE, Saint-Cyr JA, Lang AE. Parkinson's disease: cognitive changes in relation to treatment response. Brain 1987;110:35-51.
-
(1987)
Brain
, vol.110
, pp. 35-51
-
-
Taylor, A.E.1
Saint-Cyr, J.A.2
Lang, A.E.3
-
9
-
-
0023882325
-
Internal versus external cues and the control of attention in Parkinson's disease
-
Brown RG, Marsden CD. Internal versus external cues and the control of attention in Parkinson's disease. Brain 1988;111:323-345.
-
(1988)
Brain
, vol.111
, pp. 323-345
-
-
Brown, R.G.1
Marsden, C.D.2
-
10
-
-
0023937255
-
"Subcortical dementia": the neuropsychological evidence
-
Brown RG, Marsden CD. "Subcortical dementia": the neuropsychological evidence. Neuroscience 1988;25:363-387.
-
(1988)
Neuroscience
, vol.25
, pp. 363-387
-
-
Brown, R.G.1
Marsden, C.D.2
-
11
-
-
0023908443
-
Remote memory function in Alzheimer's disease and Parkinson's disease
-
Sagar HJ, Cohen NJ, Sullivan EV. Remote memory function in Alzheimer's disease and Parkinson's disease. Brain 1988;111:185-206.
-
(1988)
Brain
, vol.111
, pp. 185-206
-
-
Sagar, H.J.1
Cohen, N.J.2
Sullivan, E.V.3
-
12
-
-
0023922919
-
Temporal ordering and short-term memory deficits in Parkinson's disease
-
Sagar H, Sullivan EV Gabrieli J, et al. Temporal ordering and short-term memory deficits in Parkinson's disease. Brain 1988;111:525-539.
-
(1988)
Brain
, vol.111
, pp. 525-539
-
-
Sagar, H.1
Sullivan, E.V.2
Gabrieli, J.3
-
13
-
-
0023904094
-
A comparative study of visuospatial memory and learning in Alzheimer-type dementia and Parkinson's disease
-
Sahakian BJ, Morris RG, Evenden JL, et al. A comparative study of visuospatial memory and learning in Alzheimer-type dementia and Parkinson's disease. Brain 1988;111:695-718.
-
(1988)
Brain
, vol.111
, pp. 695-718
-
-
Sahakian, B.J.1
Morris, R.G.2
Evenden, J.L.3
-
14
-
-
0023877536
-
"Frontal" cognitive function in patients with Parkinson's disease 'on' and 'off levodopa
-
Gotham AM, Brown RG, Marsden CD. "Frontal" cognitive function in patients with Parkinson's disease 'on' and 'off levodopa. Brain 1988;111:299-321.
-
(1988)
Brain
, vol.111
, pp. 299-321
-
-
Gotham, A.M.1
Brown, R.G.2
Marsden, C.D.3
-
15
-
-
0023780253
-
Procedural learning and neostriatal dysfunction in man
-
Saint-Cyr JA, Taylor AE, Lang AE. Procedural learning and neostriatal dysfunction in man. Brain 1988;111:941-959.
-
(1988)
Brain
, vol.111
, pp. 941-959
-
-
Saint-Cyr, J.A.1
Taylor, A.E.2
Lang, A.E.3
-
16
-
-
0024602461
-
The performance on learning tasks of patients in the early stages of Parkinson's disease
-
Canavan AGM, Passingham RE, Marsden CD, et al. The performance on learning tasks of patients in the early stages of Parkinson's disease. Neuropsychologia 1989;27:141-156.
-
(1989)
Neuropsychologia
, vol.27
, pp. 141-156
-
-
Canavan, A.G.M.1
Passingham, R.E.2
Marsden, C.D.3
-
17
-
-
0024845352
-
Impaired extra-dimensional shift performance in medicated and unmedicated Parkinson's disease: evidence for a specific attentional dysfunction
-
Downes JJ, Roberts AC, Sahakian BJ, et al. Impaired extra-dimensional shift performance in medicated and unmedicated Parkinson's disease: evidence for a specific attentional dysfunction. Neuropsychologia 1989;27:1329-1343.
-
(1989)
Neuropsychologia
, vol.27
, pp. 1329-1343
-
-
Downes, J.J.1
Roberts, A.C.2
Sahakian, B.J.3
-
18
-
-
0025277135
-
Deficits on visuospatial tests involving forward planning in high-functioning parkinsonians
-
Ogden JA, Growdon JH, Corkin S. Deficits on visuospatial tests involving forward planning in high-functioning parkinsonians. Neuropsychiatry Neuropsychol Behav Neurol 1990;3:125-139.
-
(1990)
Neuropsychiatry Neuropsychol Behav Neurol
, vol.3
, pp. 125-139
-
-
Ogden, J.A.1
Growdon, J.H.2
Corkin, S.3
-
19
-
-
0025993229
-
Cognitive impairment in early, untreated Parkinson's disease and its relationship to motor disability
-
Cooper JA, Sagar H, Jordan N, et al. Cognitive impairment in early, untreated Parkinson's disease and its relationship to motor disability. Brain 1991;114:2095-2122.
-
(1991)
Brain
, vol.114
, pp. 2095-2122
-
-
Cooper, J.A.1
Sagar, H.2
Jordan, N.3
-
20
-
-
0026534848
-
L-dopa withdrawal in Parkinson's disease selectively impairs cognitive performance in tests sensitive to frontal lobe dysfunction
-
Lange KW, Robbins TW, Marsden CD, et al. L-dopa withdrawal in Parkinson's disease selectively impairs cognitive performance in tests sensitive to frontal lobe dysfunction. Psychopharmacology 1992;107:394-404.
-
(1992)
Psychopharmacology
, vol.107
, pp. 394-404
-
-
Lange, K.W.1
Robbins, T.W.2
Marsden, C.D.3
-
21
-
-
0027089916
-
Fronto-striatal cognitive deficits at different stages of Parkinson's disease
-
Owen AM, James M, Leigh PN, et al. Fronto-striatal cognitive deficits at different stages of Parkinson's disease. Brain 1992;115:1727-1751.
-
(1992)
Brain
, vol.115
, pp. 1727-1751
-
-
Owen, A.M.1
James, M.2
Leigh, P.N.3
-
22
-
-
0027161183
-
Visuospatial memory deficits at different stages of Parkinson's disease
-
Owen AM, Beksinska M, James M, et al. Visuospatial memory deficits at different stages of Parkinson's disease. Neuropsychologia 1993;31:627-644.
-
(1993)
Neuropsychologia
, vol.31
, pp. 627-644
-
-
Owen, A.M.1
Beksinska, M.2
James, M.3
-
24
-
-
0036869477
-
Memory and executive function impairment predict dementia in Parkinson's disease
-
Levy G, Jacobs DM, Tang MX, et al. Memory and executive function impairment predict dementia in Parkinson's disease. Mov Disord 2002;17:1221-1226.
-
(2002)
Mov Disord
, vol.17
, pp. 1221-1226
-
-
Levy, G.1
Jacobs, D.M.2
Tang, M.X.3
-
25
-
-
0037279168
-
Neuropsychological profile of patients with Parkinson's disease without dementia
-
Janvin C, Aarsland D, Larsen JP, et al. Neuropsychological profile of patients with Parkinson's disease without dementia. Dement Geriatr Cogn Disord 2003;15:126-131.
-
(2003)
Dement Geriatr Cogn Disord
, vol.15
, pp. 126-131
-
-
Janvin, C.1
Aarsland, D.2
Larsen, J.P.3
-
27
-
-
0023178052
-
Bradyphrenia in Parkinson's disease and psychomotor retardation in depressive illness: an experimental study
-
Rogers D, Lees AJ, Smith E, et al. Bradyphrenia in Parkinson's disease and psychomotor retardation in depressive illness: an experimental study. Brain 1987;110:761-776.
-
(1987)
Brain
, vol.110
, pp. 761-776
-
-
Rogers, D.1
Lees, A.J.2
Smith, E.3
-
28
-
-
0027486687
-
Contrasting mechanisms of impaired attentional set-shifting in patients with frontal lobe damage or Parkinson's disease
-
Owen AM, Roberts AC, Hodges JR, et al. Contrasting mechanisms of impaired attentional set-shifting in patients with frontal lobe damage or Parkinson's disease. Brain 1993:116:1159-1175.
-
(1993)
Brain
, vol.116
, pp. 1159-1175
-
-
Owen, A.M.1
Roberts, A.C.2
Hodges, J.R.3
-
29
-
-
0018725135
-
Cognitive deficit caused by regional depletion of dopamine in prefrontal cortex of rhesus monkey
-
Brozoski TJ, Brown RM, Rosvold HE, et al. Cognitive deficit caused by regional depletion of dopamine in prefrontal cortex of rhesus monkey. Science 1979;205:929-931.
-
(1979)
Science
, vol.205
, pp. 929-931
-
-
Brozoski, T.J.1
Brown, R.M.2
Rosvold, H.E.3
-
30
-
-
13844275931
-
Dopaminergic basis for deficits in working memory but not attentional set-shifting in Parkinson's disease
-
Lewis SJG, Slabosz A, Robbins TW, et al. Dopaminergic basis for deficits in working memory but not attentional set-shifting in Parkinson's disease. Neuropsychologia 2005;43:823-832.
-
(2005)
Neuropsychologia
, vol.43
, pp. 823-832
-
-
Lewis, S.J.G.1
Slabosz, A.2
Robbins, T.W.3
-
31
-
-
0036191967
-
Dopaminergic modulation of high level cognition in Parkinson's disease: the role of prefrontal cortex by PET
-
Cools R, Stefanova E, Barker RA, et al. Dopaminergic modulation of high level cognition in Parkinson's disease: the role of prefrontal cortex by PET. Brain 2002;125:584-594.
-
(2002)
Brain
, vol.125
, pp. 584-594
-
-
Cools, R.1
Stefanova, E.2
Barker, R.A.3
-
32
-
-
1242317825
-
Striatal contributions to working memory: a functional magnetic resonance imaging study in humans
-
Lewis SJG, Dove A, Robbins TW, et al. Striatal contributions to working memory: a functional magnetic resonance imaging study in humans. Eur J Neurosci 2004;19:755-760.
-
(2004)
Eur J Neurosci
, vol.19
, pp. 755-760
-
-
Lewis, S.J.G.1
Dove, A.2
Robbins, T.W.3
-
33
-
-
33748493582
-
The role of learned irrelevance in attentional set-shifting impairments in Parkinson's disease
-
Slabosz A, Lewis SJ, Smigasiewicz K, et al. The role of learned irrelevance in attentional set-shifting impairments in Parkinson's disease. Neuropsychology 2006;20:578-588.
-
(2006)
Neuropsychology
, vol.20
, pp. 578-588
-
-
Slabosz, A.1
Lewis, S.J.2
Smigasiewicz, K.3
-
34
-
-
0024431682
-
Alterations in catecholamine neurons of the locus coeruleus in senile dementia of the Alzheimer type and in Parkinson's disease with and without dementia and depression
-
Chan-Palay V, Asan E. Alterations in catecholamine neurons of the locus coeruleus in senile dementia of the Alzheimer type and in Parkinson's disease with and without dementia and depression. J Comp Neurol 1989:287:373-392.
-
(1989)
J Comp Neurol
, vol.287
, pp. 373-392
-
-
Chan-Palay, V.1
Asan, E.2
-
35
-
-
0021061754
-
A subcortico-cortical cholinergic system is affected in Parkinson's disease
-
Dubois B, Ruberg M, Javoy-Agid F, et al. A subcortico-cortical cholinergic system is affected in Parkinson's disease. Brain Res 1983;288:213-218.
-
(1983)
Brain Res
, vol.288
, pp. 213-218
-
-
Dubois, B.1
Ruberg, M.2
Javoy-Agid, F.3
-
36
-
-
0026348872
-
Pathology of Parkinson's disease. Changes other than the nigrostriatal pathway
-
Jellinger KA. Pathology of Parkinson's disease. Changes other than the nigrostriatal pathway. Mol Chem Neuropathol 1991;14:153-197.
-
(1991)
Mol Chem Neuropathol
, vol.14
, pp. 153-197
-
-
Jellinger, K.A.1
-
37
-
-
0020578137
-
Reduction of cortical dopamine, noradrenaline, serotonin and their metabolites in Parkinson's disease
-
Scatton B, Javoy-Agid F, Rouquier L, et al. Reduction of cortical dopamine, noradrenaline, serotonin and their metabolites in Parkinson's disease. Brain Res 1983;275:321-328.
-
(1983)
Brain Res
, vol.275
, pp. 321-328
-
-
Scatton, B.1
Javoy-Agid, F.2
Rouquier, L.3
-
38
-
-
10044283107
-
Rivastigmine for dementia associated with Parkinson's disease
-
Emre M, Aarsland D, Albanese A, et al. Rivastigmine for dementia associated with Parkinson's disease. N Engl J Med 2004;351:2509-2518.
-
(2004)
N Engl J Med
, vol.351
, pp. 2509-2518
-
-
Emre, M.1
Aarsland, D.2
Albanese, A.3
-
39
-
-
0347385143
-
Cortical cholinergic function is more severely affected in parkinsonian dementia than in Alzheimer disease: an in vivo positron emission tomographic study
-
Bohnen N I, Kaufer DI, Ivanco LS, et al. Cortical cholinergic function is more severely affected in parkinsonian dementia than in Alzheimer disease: an in vivo positron emission tomographic study. Arch Neurol 2003;60:1745-1748.
-
(2003)
Arch Neurol
, vol.60
, pp. 1745-1748
-
-
Bohnen, N.I.1
Kaufer, D.I.2
Ivanco, L.S.3
-
40
-
-
0037333666
-
Staging of brain pathology related to sporadic Parkinson's disease
-
Braak H, Del Tredici K, Rub U, et al. Staging of brain pathology related to sporadic Parkinson's disease. Neurobiol Aging 2003;24:197-211.
-
(2003)
Neurobiol Aging
, vol.24
, pp. 197-211
-
-
Braak, H.1
Del Tredici, K.2
Rub, U.3
-
41
-
-
0033951302
-
Probabilistic learning and reversal deficits in patients with Parkinson's disease or frontal or temporal lobe lesions: possible adverse effects of dopaminergic medication
-
Swainson R, Rogers RD, Sahakian BJ, et al. Probabilistic learning and reversal deficits in patients with Parkinson's disease or frontal or temporal lobe lesions: possible adverse effects of dopaminergic medication. Neuropsychologia 2000;38:596-612.
-
(2000)
Neuropsychologia
, vol.38
, pp. 596-612
-
-
Swainson, R.1
Rogers, R.D.2
Sahakian, B.J.3
-
42
-
-
0023874410
-
Uneven pattern of dopamine loss in the striatum of patients with idiopathic Parkinson's disease. Pathophysiologic and clinical implications
-
Kish SJ, Shannak K, Hornykiewicz O. Uneven pattern of dopamine loss in the striatum of patients with idiopathic Parkinson's disease. Pathophysiologic and clinical implications. N Engl J Med 1988;318:876-880.
-
(1988)
N Engl J Med
, vol.318
, pp. 876-880
-
-
Kish, S.J.1
Shannak, K.2
Hornykiewicz, O.3
-
43
-
-
0035191059
-
Enhanced or impaired cognitive function in Parkinson's disease as a function of dopaminergic medication and task demands
-
Cools R, Barker RA, Sahakian BJ, et al. Enhanced or impaired cognitive function in Parkinson's disease as a function of dopaminergic medication and task demands. Cereb Cortex 2001;11:1136-1143.
-
(2001)
Cereb Cortex
, vol.11
, pp. 1136-1143
-
-
Cools, R.1
Barker, R.A.2
Sahakian, B.J.3
-
44
-
-
0037707632
-
L-dopa medication remediates cognitive inflexibility, but increases impulsivity in patients with Parkinson's disease
-
Cools R, Barker RA, Sahakian BJ, et al. L-dopa medication remediates cognitive inflexibility, but increases impulsivity in patients with Parkinson's disease. Neuropsychologia 2003;41:1431-1441.
-
(2003)
Neuropsychologia
, vol.41
, pp. 1431-1441
-
-
Cools, R.1
Barker, R.A.2
Sahakian, B.J.3
-
45
-
-
49449112081
-
Parkinson's disease and dopaminergic therapy-differential effects on movement, reward and cognition
-
Rowe JB, Hughes L, Ghosh BC, et al. Parkinson's disease and dopaminergic therapy-differential effects on movement, reward and cognition. Brain 2008;131:2094-2105.
-
(2008)
Brain
, vol.131
, pp. 2094-2105
-
-
Rowe, J.B.1
Hughes, L.2
Ghosh, B.C.3
-
46
-
-
84855164495
-
Aberrant reward processing in Parkinson's disease is associated with dopamine cell loss
-
Aarts E, Helmich RC, Janssen MJR, et al. Aberrant reward processing in Parkinson's disease is associated with dopamine cell loss. Neuroimage 2012;59:3339-3346.
-
(2012)
Neuroimage
, vol.59
, pp. 3339-3346
-
-
Aarts, E.1
Helmich, R.C.2
Janssen, M.J.R.3
-
47
-
-
28044435068
-
Factors influencing susceptibility to compulsive dopaminergic drug use in Parkinson disease
-
Evans AH, Lawrence AD, Potts J, Appel S, Lees AJ. Factors influencing susceptibility to compulsive dopaminergic drug use in Parkinson disease. Neurology 2005;65:1570-1574.
-
(2005)
Neurology
, vol.65
, pp. 1570-1574
-
-
Evans, A.H.1
Lawrence, A.D.2
Potts, J.3
Appel, S.4
Lees, A.J.5
-
48
-
-
33845696933
-
L-DOPA disrupts activity in the nucleus accumbens during reversal learning in Parkinson's disease
-
Cools R, Lewis SJ, Clark L, et al. L-DOPA disrupts activity in the nucleus accumbens during reversal learning in Parkinson's disease. Neuropsychopharmacology 2007;32:180-189.
-
(2007)
Neuropsychopharmacology
, vol.32
, pp. 180-189
-
-
Cools, R.1
Lewis, S.J.2
Clark, L.3
-
49
-
-
0037057755
-
Getting formal with dopamine and reward
-
Schultz W. Getting formal with dopamine and reward. Neuron 2002;36:241-263.
-
(2002)
Neuron
, vol.36
, pp. 241-263
-
-
Schultz, W.1
-
50
-
-
34548206360
-
Disrupted prediction-error in psychosis: evidence for an associative account of delusions
-
Corlett PR, Murray GK, Honey GD, et al. Disrupted prediction-error in psychosis: evidence for an associative account of delusions. Brain 2007;130:2387-2400.
-
(2007)
Brain
, vol.130
, pp. 2387-2400
-
-
Corlett, P.R.1
Murray, G.K.2
Honey, G.D.3
-
51
-
-
0037223711
-
Psychosis as a state of aberrant salience: a framework linking biology, phenomenology, and pharmacology in schizophrenia
-
Kapur S. Psychosis as a state of aberrant salience: a framework linking biology, phenomenology, and pharmacology in schizophrenia. Am J Psychiatry 2003;160:13-23.
-
(2003)
Am J Psychiatry
, vol.160
, pp. 13-23
-
-
Kapur, S.1
-
52
-
-
0345276005
-
Neuropsychiatric non-motor aspects of Parkinson's disease
-
Thanvi BR, Munshi SK, Vijaykumar N, et al. Neuropsychiatric non-motor aspects of Parkinson's disease. Postgrad Med J 2003;79:561-565.
-
(2003)
Postgrad Med J
, vol.79
, pp. 561-565
-
-
Thanvi, B.R.1
Munshi, S.K.2
Vijaykumar, N.3
-
53
-
-
4444264056
-
Planning ability in Parkinson's disease is influenced by the COMT val158met polymorphism
-
Foltynie T, Goldberg TE, Lewis SG, et al. Planning ability in Parkinson's disease is influenced by the COMT val158met polymorphism. Mov Disord 2004;19:885-891.
-
(2004)
Mov Disord
, vol.19
, pp. 885-891
-
-
Foltynie, T.1
Goldberg, T.E.2
Lewis, S.G.3
-
54
-
-
0037947438
-
Catechol-O-methyltransferase val (158)-met genotype and individual variation in the response to amphetamine
-
Mattay VS, Callicott JH, Fera F, et al. Catechol-O-methyltransferase val (158)-met genotype and individual variation in the response to amphetamine. Proc Natl Acad Sci USA 2003;100:6186-6191.
-
(2003)
Proc Natl Acad Sci USA
, vol.100
, pp. 6186-6191
-
-
Mattay, V.S.1
Callicott, J.H.2
Fera, F.3
-
55
-
-
0034981451
-
Increased frontal [(18)F]fluorodopa uptake in early Parkinson's disease: sex differences in the prefrontal cortex
-
Kaasinen V, Nurmi E, Bruck A, et al. Increased frontal [(18)F]fluorodopa uptake in early Parkinson's disease: sex differences in the prefrontal cortex. Brain 2001;124:1125-1130.
-
(2001)
Brain
, vol.124
, pp. 1125-1130
-
-
Kaasinen, V.1
Nurmi, E.2
Bruck, A.3
-
56
-
-
0032870202
-
Frontal, midbrain and striatal dopamergic function in early and advanced Parkinson's disease. A 3D [(18)F]dopa-PET study
-
Rakshi J, Uema T, Ito K, et al. Frontal, midbrain and striatal dopamergic function in early and advanced Parkinson's disease. A 3D [(18)F]dopa-PET study. Brain 1999;122:1637-1650.
-
(1999)
Brain
, vol.122
, pp. 1637-1650
-
-
Rakshi, J.1
Uema, T.2
Ito, K.3
-
57
-
-
70350641659
-
The distinct cognitive syndromes of Parkinson's disease: 5 year follow-up of the CamPaIGN cohort
-
Williams-Gray CH, Evans JR, Goris A, et al. The distinct cognitive syndromes of Parkinson's disease: 5 year follow-up of the CamPaIGN cohort. Brain 2009;132:2958-2969.
-
(2009)
Brain
, vol.132
, pp. 2958-2969
-
-
Williams-Gray, C.H.1
Evans, J.R.2
Goris, A.3
-
58
-
-
84898817326
-
The BDNF Val66Met polymorphism has a gender specific influence on planning ability in Parkinson's disease
-
Foltynie T, Goldberg TE, Lewis SJG, et al. The BDNF Val66Met polymorphism has a gender specific influence on planning ability in Parkinson's disease. J Neurol 2005;19:885-891.
-
(2005)
J Neurol
, vol.19
, pp. 885-891
-
-
Foltynie, T.1
Goldberg, T.E.2
Lewis, S.J.G.3
-
59
-
-
0037462449
-
The BDNF val66met polymorphism affects activity-dependent secretion of BDNF and human memory and hippocampal function
-
Egan MF, Kojima M, Callicott JH, et al. The BDNF val66met polymorphism affects activity-dependent secretion of BDNF and human memory and hippocampal function. Cell 2003;112:257-269.
-
(2003)
Cell
, vol.112
, pp. 257-269
-
-
Egan, M.F.1
Kojima, M.2
Callicott, J.H.3
-
60
-
-
0035010233
-
The role of the striatum and hippocampus in planning: a PET activation study in Parkinson's disease
-
Dagher A, Owen AM, Brooks DJ. The role of the striatum and hippocampus in planning: a PET activation study in Parkinson's disease. Brain 2001;124:1020-1032.
-
(2001)
Brain
, vol.124
, pp. 1020-1032
-
-
Dagher, A.1
Owen, A.M.2
Brooks, D.J.3
-
61
-
-
84885666304
-
The CamPaIGN study of Parkinson's disease: 10-year outlook in an incident population-based cohort
-
Williams-Gray CH, Mason SL, Evans JR, Foltynie T, Brayne C, Robbins TW, Barker RA. The CamPaIGN study of Parkinson's disease: 10-year outlook in an incident population-based cohort. J Neurol Neurosurg Psychiatry 2013;84:1258-1264.
-
(2013)
J Neurol Neurosurg Psychiatry
, vol.84
, pp. 1258-1264
-
-
Williams-Gray, C.H.1
Mason, S.L.2
Evans, J.R.3
Foltynie, T.4
Brayne, C.5
Robbins, T.W.6
Barker, R.A.7
-
62
-
-
0029815726
-
A neostriatal habit learning system in humans
-
Knowlton BJ, Mangels JA, Squire LR. A neostriatal habit learning system in humans. Science 1996;273:1399-1402.
-
(1996)
Science
, vol.273
, pp. 1399-1402
-
-
Knowlton, B.J.1
Mangels, J.A.2
Squire, L.R.3
-
63
-
-
82355181048
-
The role of the basal ganglia in learning and memory: insight from Parkinson's disease
-
Foerde K, Shoramy D. The role of the basal ganglia in learning and memory: insight from Parkinson's disease. Neurobiol Learn Mem 2011;96:624-636.
-
(2011)
Neurobiol Learn Mem
, vol.96
, pp. 624-636
-
-
Foerde, K.1
Shoramy, D.2
-
64
-
-
72049125602
-
Human and rodent homologies in action control: Corticostriatal determinants of goal-directed and habitual action
-
Balleine BW, O'Doherty JP. Human and rodent homologies in action control: Corticostriatal determinants of goal-directed and habitual action. Neuropsychopharmacology 2010;35:48-69.
-
(2010)
Neuropsychopharmacology
, vol.35
, pp. 48-69
-
-
Balleine, B.W.1
O'Doherty, J.P.2
-
65
-
-
84856637225
-
Reliance on habits at the expense of goal-directed control following dopamine precursor depletion
-
de Wit S, Standing HR, Devito EE, et al. Reliance on habits at the expense of goal-directed control following dopamine precursor depletion. Psychopharmacology 2012;219:621-631.
-
(2012)
Psychopharmacology
, vol.219
, pp. 621-631
-
-
de Wit, S.1
Standing, H.R.2
Devito, E.E.3
-
66
-
-
84864935116
-
Dopamine enhances model-free over model-based choice behavior
-
Wunderlich K, Smittenaar P, Dolan R. Dopamine enhances model-free over model-based choice behavior. Neuron 2012;75:418-424.
-
(2012)
Neuron
, vol.75
, pp. 418-424
-
-
Wunderlich, K.1
Smittenaar, P.2
Dolan, R.3
-
67
-
-
15244346900
-
Lesion to the nigrostriatal dopamine system disrupts stimulus-response habit formation
-
Faure A, Haberland U, Conde F, et al. Lesion to the nigrostriatal dopamine system disrupts stimulus-response habit formation. J Neurosci 2005;25:2771-2780.
-
(2005)
J Neurosci
, vol.25
, pp. 2771-2780
-
-
Faure, A.1
Haberland, U.2
Conde, F.3
-
68
-
-
77958461569
-
Habitual versus goal-directed action control in Parkinson's disease
-
de Wit S, Barker RA, Dickinson A, et al. Habitual versus goal-directed action control in Parkinson's disease. J Cogn Neurosci 2011;23:1218-1229.
-
(2011)
J Cogn Neurosci
, vol.23
, pp. 1218-1229
-
-
de Wit, S.1
Barker, R.A.2
Dickinson, A.3
-
69
-
-
0036412603
-
Motivation, reward, and Parkinson's disease: influence of dopatherapy
-
Czernecki V, Pillon B, Houeto JL, et al. Motivation, reward, and Parkinson's disease: influence of dopatherapy. Neuropsychologia 2002;40:2257-2267.
-
(2002)
Neuropsychologia
, vol.40
, pp. 2257-2267
-
-
Czernecki, V.1
Pillon, B.2
Houeto, J.L.3
-
70
-
-
0037440814
-
Dissociating hippocampal versus basal ganglia contributions to learning and transfer
-
Myers CE, Shohamy D, Gluck MA, et al. Dissociating hippocampal versus basal ganglia contributions to learning and transfer. J Cogn Neurosci 2003;15:185-193.
-
(2003)
J Cogn Neurosci
, vol.15
, pp. 185-193
-
-
Myers, C.E.1
Shohamy, D.2
Gluck, M.A.3
-
71
-
-
77956173469
-
A neural model of hippocampal-striatal interactions in associative learning and transfer generalization in various neurological and psychiatric patients
-
Moustafa AA, Keri S, Herzallah MM, et al. A neural model of hippocampal-striatal interactions in associative learning and transfer generalization in various neurological and psychiatric patients. Brain Cogn 2010;74:132-144.
-
(2010)
Brain Cogn
, vol.74
, pp. 132-144
-
-
Moustafa, A.A.1
Keri, S.2
Herzallah, M.M.3
-
72
-
-
78649466268
-
A neurocomputational model of dopamine and prefrontal-striatal interactions during multicue category learning by Parkinson patients
-
Moustafa AA, Gluck MA. A neurocomputational model of dopamine and prefrontal-striatal interactions during multicue category learning by Parkinson patients. J Cogn Neurosci 2011;23:151-167.
-
(2011)
J Cogn Neurosci
, vol.23
, pp. 151-167
-
-
Moustafa, A.A.1
Gluck, M.A.2
-
73
-
-
84925970288
-
Fronto-striatal gray matter contributions to discrimination learning in Parkinson's disease [serial online]
-
O'Callaghan C, Moustafa AA, de Wit S, Shine JM, Robbins TW, Lewis SJ, Hornberger M. Fronto-striatal gray matter contributions to discrimination learning in Parkinson's disease [serial online]. Front Comput Neurosci 2013;7:180.
-
(2013)
Front Comput Neurosci
, vol.7
, pp. 180
-
-
O'Callaghan, C.1
Moustafa, A.A.2
de Wit, S.3
Shine, J.M.4
Robbins, T.W.5
Lewis, S.J.6
Hornberger, M.7
-
74
-
-
84861556604
-
Dopamine and performance in a reinforcement learning task: evidence from Parkinson's disease
-
Shiner T, Seymour, B, Wunderlich K. Dopamine and performance in a reinforcement learning task: evidence from Parkinson's disease. Brain 2012;135:1871-1883.
-
(2012)
Brain
, vol.135
, pp. 1871-1883
-
-
Shiner, T.1
Seymour, B.2
Wunderlich, K.3
-
75
-
-
3242781620
-
Role of the basal ganglia in category learning: how do patients with Parkinson's disease learn?
-
Shohamy D, Myers CE, Onlaor S, et al. Role of the basal ganglia in category learning: how do patients with Parkinson's disease learn? Behav Neurosci 2004;118:676-686.
-
(2004)
Behav Neurosci
, vol.118
, pp. 676-686
-
-
Shohamy, D.1
Myers, C.E.2
Onlaor, S.3
-
76
-
-
33644639638
-
L-dopa impairs learning, but spares generalization, in Parkinson's disease
-
Shohamy D, Myers CE, Geghman KD, et al. L-dopa impairs learning, but spares generalization, in Parkinson's disease. Neuropsychologia 2006;44:774-784.
-
(2006)
Neuropsychologia
, vol.44
, pp. 774-784
-
-
Shohamy, D.1
Myers, C.E.2
Geghman, K.D.3
-
77
-
-
84859359283
-
Decomposing effects of dopaminergic medication in Parkinson's disease on probabilistic action selection-learning or performance?
-
Smittenaar P, Chase HW, Aarts E, et al. Decomposing effects of dopaminergic medication in Parkinson's disease on probabilistic action selection-learning or performance? Eur J Neurosci 2012;35:1144-1151.
-
(2012)
Eur J Neurosci
, vol.35
, pp. 1144-1151
-
-
Smittenaar, P.1
Chase, H.W.2
Aarts, E.3
-
78
-
-
77955271192
-
Rule-based categorization deficits in focal basal ganglia lesion and Parkinson's disease patients
-
Ell SW, Weinstein A, Ivry RB. Rule-based categorization deficits in focal basal ganglia lesion and Parkinson's disease patients. Neuropsychologia 2010;48:2974-2986.
-
(2010)
Neuropsychologia
, vol.48
, pp. 2974-2986
-
-
Ell, S.W.1
Weinstein, A.2
Ivry, R.B.3
-
79
-
-
10344250993
-
By carrot or by stick: cognitive reinforcement learning in parkinsonism
-
Frank MJ, Seeberger LC, O'Reilly RC. By carrot or by stick: cognitive reinforcement learning in parkinsonism. Science 2004;306:1940-1943.
-
(2004)
Science
, vol.306
, pp. 1940-1943
-
-
Frank, M.J.1
Seeberger, L.C.2
O'Reilly, R.C.3
-
80
-
-
12544251990
-
Dynamic dopamine modulation in the basal ganglia: a neurocomputational account of cognitive deficits in medicated and nonmedicated parkinsonism
-
Frank MJ. Dynamic dopamine modulation in the basal ganglia: a neurocomputational account of cognitive deficits in medicated and nonmedicated parkinsonism. J Cogn Neurosci 2005;17:51-72.
-
(2005)
J Cogn Neurosci
, vol.17
, pp. 51-72
-
-
Frank, M.J.1
-
81
-
-
33745285708
-
Reversal learning in Parkinson's disease depends on medication status and outcome valence
-
Cools R, Altamirano L, D'Esposito M. Reversal learning in Parkinson's disease depends on medication status and outcome valence. Neuropsychologia 2006;44:1663-1673.
-
(2006)
Neuropsychologia
, vol.44
, pp. 1663-1673
-
-
Cools, R.1
Altamirano, L.2
D'Esposito, M.3
-
82
-
-
58149379028
-
A role for dopamine in temporal decision making and reward maximization in parkinsonism
-
Moustafa A, Cohen MX, Sherman SJ, et al. A role for dopamine in temporal decision making and reward maximization in parkinsonism. J. Neurosci 2008;28:12294-12304.
-
(2008)
J. Neurosci
, vol.28
, pp. 12294-12304
-
-
Moustafa, A.1
Cohen, M.X.2
Sherman, S.J.3
-
83
-
-
70349922298
-
Reward-learning and the novelty-seeking personality: a between-and within-subjects study of the effects of dopamine agonists on young Parkinson's patients
-
Bodi N, Keri S, Nagy H, et al. Reward-learning and the novelty-seeking personality: a between-and within-subjects study of the effects of dopamine agonists on young Parkinson's patients. Brain 2009;132;2385-2395.
-
(2009)
Brain
, vol.132
, pp. 2385-2395
-
-
Bodi, N.1
Keri, S.2
Nagy, H.3
-
84
-
-
73149090095
-
Pharmacological modulation of subliminal learning in Parkinson's and Tourette's syndromes
-
Palminteri S, Lebreton M, Worbe Y, et al. Pharmacological modulation of subliminal learning in Parkinson's and Tourette's syndromes. Proc Natl Acad Sci USA 2009;106:19179-19184.
-
(2009)
Proc Natl Acad Sci USA
, vol.106
, pp. 19179-19184
-
-
Palminteri, S.1
Lebreton, M.2
Worbe, Y.3
-
85
-
-
73549113279
-
Mechanisms underlying dopamine-mediated reward bias in compulsive behaviors
-
Voon V, Pessiglione M, Brezing C, et al. Mechanisms underlying dopamine-mediated reward bias in compulsive behaviors. Neuron 2010;65:135-142.
-
(2010)
Neuron
, vol.65
, pp. 135-142
-
-
Voon, V.1
Pessiglione, M.2
Brezing, C.3
-
86
-
-
72849112662
-
Dopaminergic drugs modulate learning rates and perseveration in Parkinson's patients in a dynamic foraging task
-
Rutledge RB, Lazzaro SC, Lau B, et al. Dopaminergic drugs modulate learning rates and perseveration in Parkinson's patients in a dynamic foraging task. J. Neurosci 2009;29:15104-15114.
-
(2009)
J. Neurosci
, vol.29
, pp. 15104-15114
-
-
Rutledge, R.B.1
Lazzaro, S.C.2
Lau, B.3
-
87
-
-
33847634405
-
The debate over dopamine's role in reward: the case for incentive salience
-
Berridge KC. The debate over dopamine's role in reward: the case for incentive salience. Psychopharmacology 2007;191:391-431.
-
(2007)
Psychopharmacology
, vol.191
, pp. 391-431
-
-
Berridge, K.C.1
-
88
-
-
33847662975
-
A role for mesencephalic dopamine in activation: commentary on Berridge (2006)
-
Robbins TW, Everitt BJ. A role for mesencephalic dopamine in activation: commentary on Berridge (2006). Psychopharmacology 2007;191:433-437.
-
(2007)
Psychopharmacology
, vol.191
, pp. 433-437
-
-
Robbins, T.W.1
Everitt, B.J.2
-
89
-
-
17844367586
-
Time-limited modulation of appetitive Pavlovian memory by D1 and NMDA receptors in the nucleus accumbens
-
Dalley JW, Laane K, Theobald DEH, et al. Time-limited modulation of appetitive Pavlovian memory by D1 and NMDA receptors in the nucleus accumbens. Proc Natl Acad Sci USA 2005;102:6189-6194.
-
(2005)
Proc Natl Acad Sci USA
, vol.102
, pp. 6189-6194
-
-
Dalley, J.W.1
Laane, K.2
Theobald, D.E.H.3
-
90
-
-
84857434399
-
Apathy blunts neural response to money in Parkinson's disease
-
Lawrence AD, Goerendt IK, Brooks DJ. Apathy blunts neural response to money in Parkinson's disease. Soc Neurosci 2011;6:653-662.
-
(2011)
Soc Neurosci
, vol.6
, pp. 653-662
-
-
Lawrence, A.D.1
Goerendt, I.K.2
Brooks, D.J.3
-
91
-
-
83155189109
-
Contributions of the ventromedial prefrontal cortex to goal-directed action selection
-
O'Doherty JP. Contributions of the ventromedial prefrontal cortex to goal-directed action selection. Ann NY Acad Sci 2011;1239:118-129.
-
(2011)
Ann NY Acad Sci
, vol.1239
, pp. 118-129
-
-
O'Doherty, J.P.1
-
92
-
-
28844448732
-
Dopaminergic modulation of cognitive function-implications for L-DOPA treatment in Parkinson's disease
-
Cools R. Dopaminergic modulation of cognitive function-implications for L-DOPA treatment in Parkinson's disease. Neurosci Biobehav Rev 2006;30:1-23.
-
(2006)
Neurosci Biobehav Rev
, vol.30
, pp. 1-23
-
-
Cools, R.1
-
93
-
-
33646468355
-
Impaired dimensional selection but intact use of reward feedback during visual discrimination learning in Parkinson's disease
-
Swainson R, SenGupta D, Shetty T, et al. Impaired dimensional selection but intact use of reward feedback during visual discrimination learning in Parkinson's disease. Neuropsychologia 2006;44:1290-1304.
-
(2006)
Neuropsychologia
, vol.44
, pp. 1290-1304
-
-
Swainson, R.1
SenGupta, D.2
Shetty, T.3
-
94
-
-
61949486980
-
Rule-based category learning in patients with Parkinson's disease
-
Price A, Filoteo JV, Maddox WT. Rule-based category learning in patients with Parkinson's disease. Neuropsychologia 2009;47:1213-1226.
-
(2009)
Neuropsychologia
, vol.47
, pp. 1213-1226
-
-
Price, A.1
Filoteo, J.V.2
Maddox, W.T.3
-
96
-
-
84898788380
-
Selective serotonin reuptake inhibition modulates impulsivity in Parkinson's disease
-
in press.
-
Zheng Y, Altena E, Nombela-Otero C, et al. Selective serotonin reuptake inhibition modulates impulsivity in Parkinson's disease. Brain 2014, in press.
-
(2014)
Brain
-
-
Zheng, Y.1
Altena, E.2
Nombela-Otero, C.3
-
97
-
-
77955404787
-
Atomoxetine for depression and other neuropsychiatric symptoms in Parkinson disease
-
Weintraub D, Mavandadi S, E. Mamikonyan E, et al. Atomoxetine for depression and other neuropsychiatric symptoms in Parkinson disease. Neurology 2010;75:448-455.
-
(2010)
Neurology
, vol.75
, pp. 448-455
-
-
Weintraub, D.1
Mavandadi, S.E.2
Mamikonyan, E.3
-
98
-
-
61649118193
-
Atomoxetine for the treatment of executive dysfunction in Parkinson's disease: a pilot open-label study
-
Marsh L, Biglan K, Gerstenhaber M, et al. Atomoxetine for the treatment of executive dysfunction in Parkinson's disease: a pilot open-label study. Mov Disord 2009;24:277-282.
-
(2009)
Mov Disord
, vol.24
, pp. 277-282
-
-
Marsh, L.1
Biglan, K.2
Gerstenhaber, M.3
-
99
-
-
84898788486
-
Improving impulsivity in Parkinson's disease by atomoxetine
-
In press.
-
Zheng Y, Altena E, Nombela-Otero C, et al. Improving impulsivity in Parkinson's disease by atomoxetine. Biol Psychiatry 2014. In press.
-
(2014)
Biol Psychiatry
-
-
Zheng, Y.1
Altena, E.2
Nombela-Otero, C.3
-
100
-
-
0029348250
-
Acetylcholine and hallucinations: disease-related compared to drug-induced alterations in human consciousness
-
Perry EK, Perry RH. Acetylcholine and hallucinations: disease-related compared to drug-induced alterations in human consciousness. Brain Cogn 1995;28:240-258.
-
(1995)
Brain Cogn
, vol.28
, pp. 240-258
-
-
Perry, E.K.1
Perry, R.H.2
-
101
-
-
78349310514
-
Neuropsychological and clinical heterogeneity of cognitive impairment and dementia in Parkinson's disease
-
Kehagia AA, Barker RA, Robbins TW. Neuropsychological and clinical heterogeneity of cognitive impairment and dementia in Parkinson's disease. Lancet Neurol 2010;9:1200-1213.
-
(2010)
Lancet Neurol
, vol.9
, pp. 1200-1213
-
-
Kehagia, A.A.1
Barker, R.A.2
Robbins, T.W.3
-
102
-
-
34447633928
-
Evolution of cognitive dysfunction in an incident Parkinson's disease cohort
-
Williams-Gray CH, Foltynie T, Brayne CE, et al. Evolution of cognitive dysfunction in an incident Parkinson's disease cohort. Brain 2007;130:1787-1798.
-
(2007)
Brain
, vol.130
, pp. 1787-1798
-
-
Williams-Gray, C.H.1
Foltynie, T.2
Brayne, C.E.3
-
103
-
-
35148866228
-
Tau and alpha-synuclein in susceptibility to, and dementia in, Parkinson's disease
-
Goris A, Williams-Gray CH, Clark GR, et al. Tau and alpha-synuclein in susceptibility to, and dementia in, Parkinson's disease. Ann Neurol 2007:62:145-153.
-
(2007)
Ann Neurol
, vol.62
, pp. 145-153
-
-
Goris, A.1
Williams-Gray, C.H.2
Clark, G.R.3
-
104
-
-
84895770516
-
Characterising mild cognitive impairment in incident Parkinson's disease: the ICICLE PD study
-
Yarnall AY, Breen DP, Duncan GW, et al. Characterising mild cognitive impairment in incident Parkinson's disease: the ICICLE PD study. Neurology 2014;82:308-316.
-
(2014)
Neurology
, vol.82
, pp. 308-316
-
-
Yarnall, A.Y.1
Breen, D.P.2
Duncan, G.W.3
-
105
-
-
27844469751
-
A systematic review of prevalence studies of dementia in Parkinson's disease
-
Aarsland D, Zaccai J, Brayne C. A systematic review of prevalence studies of dementia in Parkinson's disease. Mov Disord 2005;20:1255-1263.
-
(2005)
Mov Disord
, vol.20
, pp. 1255-1263
-
-
Aarsland, D.1
Zaccai, J.2
Brayne, C.3
-
106
-
-
1542375990
-
The cognitive ability of an incident cohort of Parkinson's patients in the UK
-
Foltynie T, Brayne CE, Robbins TW, et al. The cognitive ability of an incident cohort of Parkinson's patients in the UK. The CamPaIGN study. Brain 2004;127:550-560.
-
(2004)
The CamPaIGN study. Brain
, vol.127
, pp. 550-560
-
-
Foltynie, T.1
Brayne, C.E.2
Robbins, T.W.3
-
108
-
-
0029882343
-
Neural systems engaged by planning: a PET study of the Tower of London task
-
Baker SC, Rogers RD, Owen AM, et al. Neural systems engaged by planning: a PET study of the Tower of London task. Neuropsychologia 1996;34:515-526.
-
(1996)
Neuropsychologia
, vol.34
, pp. 515-526
-
-
Baker, S.C.1
Rogers, R.D.2
Owen, A.M.3
-
109
-
-
0028945150
-
Visuo-spatial short-term recognition memory and learning after temporal lobe excisions, frontal lobe excisions or amygdalo-hippocampectomy in man
-
Owen AM, Sahakian BJ, Semple J, et al. Visuo-spatial short-term recognition memory and learning after temporal lobe excisions, frontal lobe excisions or amygdalo-hippocampectomy in man. Neuropsychologia 1995;33:1-24.
-
(1995)
Neuropsychologia
, vol.33
, pp. 1-24
-
-
Owen, A.M.1
Sahakian, B.J.2
Semple, J.3
-
110
-
-
14544303625
-
Heterogeneity of Parkinson's disease in the early clinical stages using a data driven approach
-
Lewis SJG, Foltynie T, Blackwell AD, et al. Heterogeneity of Parkinson's disease in the early clinical stages using a data driven approach. J Neurol Neurosurg Psychiatry 2005;76:343-348.
-
(2005)
J Neurol Neurosurg Psychiatry
, vol.76
, pp. 343-348
-
-
Lewis, S.J.G.1
Foltynie, T.2
Blackwell, A.D.3
-
111
-
-
34247897260
-
Catechol-O-methyltransferase Val158Met genotype influences frontoparietal activity during planning in patients with Parkinson's disease
-
Williams-Gray CH, Hampshire A, Robbins TW, et al. Catechol-O-methyltransferase Val158Met genotype influences frontoparietal activity during planning in patients with Parkinson's disease. J Neurosci 2007;27:4832-4838.
-
(2007)
J Neurosci
, vol.27
, pp. 4832-4838
-
-
Williams-Gray, C.H.1
Hampshire, A.2
Robbins, T.W.3
|